Hypokalemic periodic paralysis is a rare autosomal dominant channelopathy marked by attacks of muscle weakness or paralysis that accompany a fall in blood potassium. Attacks often begin in childhood or adolescence and are triggered by rest after strenuous exercise, large carbohydrate or salty meals, sudden temperature changes, stress or certain medications. They can last from hours to days, and strength usually returns between attacks, though some people develop lasting weakness later in life. A related form that appears only with an overactive thyroid is called thyrotoxic periodic paralysis. Mutations in muscle ion channel genes underlie the condition, although many cases are sporadic. In 1935 the Scottish physician Mary Walker first recognised the link with low potassium and described the glucose challenge test and intravenous potassium treatment.
Facts
Classification
ICD-10 ChapterVI: Diseases of the Nervous System 2 Communicable or Non-communicable First Described Prevalence Band Causative Agent
Causative Agent (category) Sources
1. Hypokalemic periodic paralysis (Wikipedia)
Lead
is a rare, autosomal dominant channelopathy characterized by muscle weakness or paralysis
Genetics
This condition is inherited in an autosomal dominant pattern (but with a high proportion of sporadic cases)
Lead [body-system]
characterized by muscle weakness or paralysis when there is a fall in potassium levels in the blood (hypokalemia)
History
In 1935 the Scottish physician Dr Mary Walker was the first to recognise the association between familial periodical paralysis and hypokalaemia.
View the Source2. World Health Organization: ICD-10 Version:2019, Chapter VI, G70-G73
World Health OrganizationICD-10 2019 category G72.3Quote, ICD-10 2019 category G72.3
G72.3 Periodic paralysis
View the Source 3. Orphadata (Orphanet): Orphadata epidemiology, ORPHAcode 681
Orphadata (Orphanet)Orphanet epidemiology, ORPHAcode 681Quote, Orphanet epidemiology, ORPHAcode 681
"PrevalenceClass": "1-9 / 100 000", "PrevalenceGeographic": "Europe", "PrevalenceQualification": "Value and class", "PrevalenceType": "Point prevalence"
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.